| 标题 |
Pembrolizumab vs cemiplimab for the treatment of advanced non-small cell lung cancer with PD-L1 expression levels of at least 50%: A network meta-analysis and cost-effectiveness analysis |
| 网址 | |
| DOI | |
| 其它 |
期刊:Frontiers in Oncology 作者:Yan Li; Xueyan Liang; Tong Yang; Sitong Guo; Xiaoyu Chen 出版日期:2022-09-26 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)